The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 26, 2020

Filed:

Jun. 12, 2017
Applicant:

Vaccinex, Inc., Rochester, NY (US);

Inventors:

Ernest S. Smith, W. Henrietta, NY (US);

Tracy Pandina, Rochester, NY (US);

Leslie A. Balch, Lakeville, NY (US);

Mark Paris, Mendon, NY (US);

Maurice Zauderer, Pittsford, NY (US);

Angelica Cornelison, Pittsford, NY (US);

Renee Kirk, Bloomfield, NY (US);

Assignee:

Vaccinex, Inc., Rochester, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C40B 40/08 (2006.01); C12N 15/10 (2006.01); C07K 16/00 (2006.01); C07K 14/005 (2006.01); C12N 15/86 (2006.01); C07K 16/28 (2006.01); C07K 16/32 (2006.01); C40B 30/04 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1037 (2013.01); C07K 14/005 (2013.01); C07K 16/00 (2013.01); C07K 16/005 (2013.01); C07K 16/2803 (2013.01); C07K 16/32 (2013.01); C12N 15/86 (2013.01); C07K 2317/522 (2013.01); C07K 2317/56 (2013.01); C07K 2319/03 (2013.01); C12N 2710/24122 (2013.01); C12N 2710/24143 (2013.01); C40B 30/04 (2013.01); C40B 40/08 (2013.01);
Abstract

The present invention relates to a high efficiency method of expressing immunoglobulin molecules in eukaryotic cells. The invention is further drawn to a method of producing immunoglobulin heavy and light chain libraries, particularly using the trimolecular recombination method, for expression in eukaryotic cells. The invention further provides methods of selecting and screening for antigen-specific immunoglobulin molecules, and antigen-specific fragments thereof. The invention also provides kits for producing, screening and selecting antigen-specific immunoglobulin molecules. Finally, the invention provides immunoglobulin molecules, and antigen-specific fragments thereof, produced by the methods provided herein.


Find Patent Forward Citations

Loading…